ULTRASOUND-GUIDED CORE NEEDLE BIOPSY VALUE IN THE DIAGNOSIS OF PEDIATRIC RETROPERITONAL TUMORS

Hương Nguyễn Thị Thanh, Công Lê Đình, Long Nguyễn Văn, Mạnh Nguyễn Thế, Ninh Trần Phan, Lưu Vũ Đăng

Main Article Content

Abstract

Objective: This study was to evaluate the diagnostic value of ultrasound-guided core needle biopsy (CNB) for pediatric retroperitoneal tumors and the complications related to procedure. Subjects and Methods: the study was conducted on 110 children diagnosed with retroperitoneal tumor underwent CNB at the Vietnam National Children’s Hospital from July 2024 to April 2025. Evaluated parameters including general characteristics, imaging features, pathological results, adverse event features. Results: Overall biopsy adequacy rate (defined as sufficient to make a diagnosis) was 99.1%. There were 7 benign tumors, and 102 malignant tumors. In determining malignant lesions, CNB showed a sensitivity of 97.1%, a specificity of 100%, an accuracy of 97.2%. Forty-five patients underwent surgery, needle biopsy and surgery had high concordance in histopathological diagnosis (Kappa coefficient = 0.63). There were 6 cases (5.4%) of post procedure complications, of which one severe bleeding requiring blood transfusion accounting for 0.9%. Conclusion: Ultrasound-guided core needle biopsy is a minimally invasive, safe and accurate technique for histopathological diagnosis and genetic biology, with a low rate of complications, it can replace surgical biopsy in the diagnosis of retroperitoneal tumors in children.

Article Details

References

1. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors in Children and adolescents: An Overview. Pediatrics In Review. 2018;39(9):444-453. doi:10.1542/pir.2017-0268
2. Sebire NJ, Roebuck DJ. Pathological diagnosis of paediatric tumours from image-guided needle core biopsies: a systematic review. Pediatr Radiol. 2006;36(5): 426-431. doi:10.1007/s00247-006-0123-4
3. Mullassery D, Sharma V, Salim A, et al. Open versus needle biopsy in diagnosing neuroblastoma. Journal of Pediatric Surgery. 2014;49(10): 1505-1507. doi: 10.1016/j.jpedsurg. 2014.05.015
4. Brisse HJ, McCarville MB, Granata C, et al. Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project. Radiology. 2011;261(1): 243-257. doi:10.1148/ radiol.11101352
5. Zhao L, Mu J, Du P, et al. Ultrasound-guided core needle biopsy in the diagnosis of neuroblastic tumors in children: a retrospective study on 83 cases. Pediatr Surg Int. 2017;33(3):347-353. doi:10.1007/s00383-016-4037-4
6. Petit S, Vallin C, Morel B, et al. A single enhanced phase is sufficient for the initial computed tomography evaluation of retroperitoneal tumors in children. Diagnostic and Interventional Imaging. 2017;98(1):73-78. doi: 10.1016/j.diii.2016.03.017
7. Overman RE, Kartal TT, Cunningham AJ, et al. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma. Pediatric Blood & Cancer. 2020;67(5): e28153. doi:10.1002/pbc.28153
8. Garrett KM, Fuller CE, Santana VM, Shochat SJ, Hoffer FA. Percutaneous biopsy of pediatric solid tumors. Cancer. 2005;104(3):644-652. doi:10.1002/cncr.21193